BRPI0718019A2 - Uso de timosina alfa 1 para a preparação de um medicamento para a prevenção e tratamento de alergias. - Google Patents

Uso de timosina alfa 1 para a preparação de um medicamento para a prevenção e tratamento de alergias. Download PDF

Info

Publication number
BRPI0718019A2
BRPI0718019A2 BRPI0718019-5A BRPI0718019A BRPI0718019A2 BR PI0718019 A2 BRPI0718019 A2 BR PI0718019A2 BR PI0718019 A BRPI0718019 A BR PI0718019A BR PI0718019 A2 BRPI0718019 A2 BR PI0718019A2
Authority
BR
Brazil
Prior art keywords
treatment
allergies
prevention
preparation
alpha
Prior art date
Application number
BRPI0718019-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Luigina Romani
Francesco Bistoni
Enrico Garaci
Guido Rasi
Paola Sinibaldi Vallebona
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BRPI0718019A2 publication Critical patent/BRPI0718019A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0718019-5A 2006-10-27 2007-09-27 Uso de timosina alfa 1 para a preparação de um medicamento para a prevenção e tratamento de alergias. BRPI0718019A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000583A ITRM20060583A1 (it) 2006-10-27 2006-10-27 Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
ITRM2006A000583 2006-10-27
PCT/IT2007/000676 WO2008050362A2 (en) 2006-10-27 2007-09-27 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies

Publications (1)

Publication Number Publication Date
BRPI0718019A2 true BRPI0718019A2 (pt) 2013-11-19

Family

ID=39322638

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718019-5A BRPI0718019A2 (pt) 2006-10-27 2007-09-27 Uso de timosina alfa 1 para a preparação de um medicamento para a prevenção e tratamento de alergias.

Country Status (13)

Country Link
US (1) US20090270594A1 (https=)
EP (1) EP2083847A2 (https=)
JP (1) JP2010507649A (https=)
KR (1) KR20090092267A (https=)
CN (1) CN101626778A (https=)
AU (1) AU2007310415A1 (https=)
BR (1) BRPI0718019A2 (https=)
CA (1) CA2666562A1 (https=)
EA (1) EA200900603A1 (https=)
IL (1) IL198290A0 (https=)
IT (1) ITRM20060583A1 (https=)
MX (1) MX2009004237A (https=)
WO (1) WO2008050362A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
AR020102A1 (es) * 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
US20060121029A1 (en) * 2002-08-30 2006-06-08 Hiroshi Shiku Method and composition for regulating the activity of regulatory t cells
DK1613340T3 (da) * 2003-03-28 2010-08-30 Sciclone Pharmaceuticals Inc Behandling af aspergillus-infektioner med thymosin alfa 1

Also Published As

Publication number Publication date
CA2666562A1 (en) 2008-05-02
WO2008050362A3 (en) 2008-07-10
EP2083847A2 (en) 2009-08-05
ITRM20060583A1 (it) 2008-04-28
EA200900603A1 (ru) 2009-10-30
AU2007310415A1 (en) 2008-05-02
MX2009004237A (es) 2009-07-07
JP2010507649A (ja) 2010-03-11
CN101626778A (zh) 2010-01-13
US20090270594A1 (en) 2009-10-29
IL198290A0 (en) 2011-08-01
KR20090092267A (ko) 2009-08-31
WO2008050362A2 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
US20120128597A1 (en) Composition for prevention and treatment of allergic and/or inflammatory diseases
Wu et al. Neuroprotective effect of chitosan oligosaccharide on hypoxic-ischemic brain damage in neonatal rats
JP2020503248A (ja) 疼痛の予防、緩和または治療における神経興奮性損傷関連ポリペプチドの使用
JP2022524899A (ja) ＨＡＰＬＮ１（ｈｙａｌｕｒｏｎａｎ ａｎｄ ｐｒｏｔｅｏｇｌｙｃａｎ ｌｉｎｋ ｐｒｏｔｅｉｎ １）を含む肺疾患の予防用または治療用の組成物
Zhu et al. Edaravone alleviated allergic airway inflammation by inhibiting oxidative stress and endoplasmic reticulum stress
Sheikh et al. Topical delivery of lipid based amphotericin B gel in the treatment of fungal infection: A clinical efficacy, safety and tolerability study in patients
JP6671671B1 (ja) アレルギー性鼻炎の予防及び／又は治療薬
BRPI0718019A2 (pt) Uso de timosina alfa 1 para a preparação de um medicamento para a prevenção e tratamento de alergias.
WO1994028153A2 (en) Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
EP4125850B1 (en) Sodium butyrate for use in the prevention or treatment of rhinovirus infection
JPH07508010A (ja) ＤＮＡウイルス感染の治療のための薬物の製造のための膜翅類昆虫（ｈｙｍｅｎｏｐｔｅｒａ）毒の使用
Trofimova et al. Medicinal Peptide Drugs: A Promising Direction in Modern Pharmacology
ES2377381B1 (es) Uso de una combinación de n-acetil-cisteína y ácido lipoico para la preparación de un medicamento útil para el tratamiento de una enfermedad con daño axonal y lesiones oxidativas concomitantes.
Liu The role of vitamin D in innate immunity: antimicrobial activity, oxidative stress and barrier function
Ping-Chung et al. Therapeutic protection against COVID-19 infection while waiting for herd immunity
US20070207130A1 (en) Stem cell therapy to treat symptoms of avian flu and other diseases
ES2931431B2 (es) Tratamiento de la enfermedad de charcot-marie-tooth
JP2010507650A (ja) 自己免疫疾患の予防及び治療用の薬剤を調製するためのチモシンアルファ１の使用
RU2643591C1 (ru) Средство для стимуляции регенерации ткани печени при парентеральном введении и способ стимуляции регенерации ткани печени на его основе
CN104434981A (zh) 眼镜蛇蛇毒在制备治疗慢性阻塞性肺疾病药物中的应用
CN110234335B (zh) 治疗女性性功能障碍的药物组合物和方法
US20200289473A1 (en) Methods of treating neurodegeneration
WO2005042015A1 (en) Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof
Nurbek et al. Features of the therapeutic scheme of ascaridosis treatment in Kazakhstan
WO2016169571A1 (en) Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.